What the business is, and whether it's a good one at a fair price.
Sells personal care products in India across two flagship brand families: feminine hygiene (Whisper) and health care (Vicks). Whisper leads India's feminine care category with nearly half the market, selling sanitary pads and period pants to women; the femcare category itself still has sub-50% consumer penetration, which management flags as a runway. Vicks holds more than 50% share in India's Cough & Cold category, selling products such as VapoRub, Cough Syrup, Steam Pods, Double Power drops and ZzzQuil sleep supplements to households. Distribution reach expanded by 1 million stores over three years, with e-commerce and quick commerce (including a Zepto co-creation for Whisper Period Pants) cited as key growth channels. The cost stack is dominated by other operating expenses at 31.2% of revenue and materials at 17.2%, with a productivity programme delivering Rs 93 cr of savings in FY25 and Rs 86 cr in FY26, fully reinvested into brand and product superiority. FY26 revenue stood at Rs 4,290.42 cr with an EBITDA margin of 28.28%.
Measured from the filed financials, judged against its Personal Care peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from P&G HYGIENE & HEALTH CARE's filed financials and exchange disclosures
P&G HYGIENE & HEALTH CARE is a Personal Products company listed on NSE and BSE, trading under the symbol PGHH.
Yes. Over the trailing twelve months P&G HYGIENE & HEALTH CARE reported a net profit of ₹791 Cr on revenue of ₹4,245 Cr.
Yes. The dividend yield is 3.46% at the current price. It paid out 99% of its profit as dividend in FY26.
Effectively yes. It holds ₹557 Cr more cash than debt. Debt stands at 0.00× equity.
On trailing P/E, P&G HYGIENE & HEALTH CARE ranks 4 of 15 in Personal Care — cheaper than 79% of them, against an industry median of 36.3×. This is a position, not a valuation judgement.
On a typical session P&G HYGIENE & HEALTH CARE moves 0.67% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by P&G HYGIENE & HEALTH CARE appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.